age with rubella vaccine in the regular immunization program; (2) conducting periodic supplemental immunization activities to increase rubella immunity in the infant, child, adolescent, and adult populations (especially women of childbearing age); (3) implementing high-quality surveillance for rash and fever illness, supported with rapid laboratory confirmation; and (4) conducting rapid outbreak response measures.
The experience that countries throughout the Americas have had in implementing these strategies has proven their effectiveness. The experience also suggests that even in countries with relatively low immunization coverage, rubella vaccine can be safely introduced when accompanied by well-organized supplementary immunization activities aimed at reducing rubella susceptibility in older age groups.
One of the key lessons learned recently with measles control in the Americas is that when measles virus circulation is interrupted, rubella virus circulation becomes readily apparent. This clearly highlights how progress in disease control can create opportunities to learn more about the burden of other vaccine-preventable diseases that are not being fully addressed in the national immunization program. Robertson et al. (1) report that in Brazil between 1993 and 1996 nearly 50% of the cases in which measles was ruled out were subsequently diagnosed as rubella. Similarly, the introduction of Haemophilus influenzae type b vaccine has accelerated efforts to understand other causes of pneumonia and meningitis, such as pneumococcal infection.
The gap between the new vaccine technologies available to industrialized nations and those available to developing countries must be narrowed, and this will be a key priority for the Immunization Unit of PAHO over the next 5 to 10 years. Other priorities for the Immunization Unit will be to help eliminate rubella and CRS, sustain the success of measles elimination, maintain the achievements of polio eradication, and strengthen the management of information within the Region of the Americas. A critical cross-cutting component of these priorities will be strengthening routine immunization services.
For the PAHO team it is an honor to work with the immunization managers of all our Member States, who continue to accomplish amazing things and to break new ground in the field of public health. Our immunization team at PAHO is strongly committed to assisting countries in providing the best immunization services possible to all children of the Americas, regardless of family income or family origin.
